acfp 61st asa: what’s up doc? colorectal … › wp-content › uploads › 2016 › 06 ›...
TRANSCRIPT
1
COLORECTAL CANCER SCREENING IN ALBERTA: INAPPROPRIATE USE OF THE FECAL IMMUNOCHEMICAL TEST (FIT) Clarence Wong, MD FRCPC Director Alberta Colorectal Cancer Screening Program
ACFP 61st ASA: What’s Up Doc?
2
Disclosures • Presenter: Clarence Wong
• Relationships that may introduce potential bias and/or conflict of
interest:
• Grants/Research Support: Covidien • Speakers Bureau/Honoraria: Takeda • Consulting Fees: Boston Scientific, Ferring, Takeda, Pendopharm,
Allergan • Other: Employer: Alberta Health Services
3
Introduction
CRC Magnitude in Alberta
4
Introduction
CRC Screening Guidelines
5
2016 CTFPHC CRC Guidelines
“We recommend screening adults aged 50 to 74 years for colorectal cancer with FOBT (either gFOBT or FIT) every two years…” “We recommend not using colonoscopy as a screening test for colorectal cancer.”
6
What is FIT? • Fecal Immunochemical Test • Primary screening test for colorectal
cancer – Also detects colonic adenomas
• More sensitive than guaiac • Antibody to globin • Colonic bleeding specific • Never designed as a diagnostic test for
symptomatic patients
7
FIT – Appropriate/Inappropriate Use
Appropriate FIT
• Average Risk CRC Screening – Asymptomatic 50-74
• Moderate Risk CRC Screening – FHx – FDR > age 60
Inappropriate FIT
• Screening Outside Age range
• Before recommended Screening Intervals
• Diagnostic Testing
• In Alberta, FIT is ordered through Primary Care •This is classified as opportunistic screening
8
Study Aim
• To identify indicators leading to inappropriate use of FIT by referring practitioners as well as best practices to facilitate the appropriate use of FIT.
9
Methods • Setting/Population: FIT performed in Alberta
• Data source: Provincial Cancer Screening (PCS) database
– The PCS database currently has data feeds from the provincial laboratories
(Calgary Laboratory Services and Dynalife), Alberta Person Directory and Alberta Cancer Registry.
– Colonoscopy Data: NACRS (National Ambulatory Care Reporting System), DAD (Discharge Abstract Database), Physician Billing Data
• AHS Facilities • Linked to FIT use
• Time period: October 2014 – January 2016
10
Methods 2 • Analysis of FIT use, demographics, zonal use, followup of
positive and negative results, correlation with colonoscopy
• Study Questions: 1. Was FIT used outside of recommended age range?
2. Were appropriate intervals followed for FIT testing?
3. Was FIT used for diagnostic purposes?
11
Fecal Tests in Target Population 2013-2014
Date Target population
Number of people had FIT
Provincial screening rate
Jan 1/13 –Dec 31/14 1,060, 108 443, 026 41.8%
FIT Introduced November 2013
13
Distribution of FIT use, by age group, by zone and provincially, July 1 2014 to June 31 2015
5.1% 7.6% 6.6% 6.7% 8.2% 6.8%
85.7% 82.4% 79.6% 81.3% 80.8% 82.0%
9.2% 10.0% 14.1% 12.1% 10.7% 11.2%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
South Calgary Central Edmonton North Alberta
outisde of target age50-74 years40-49 years
Target Age
N=268,408
14
Percent of FIT+, by age group, Alberta, July 1 2014 to June 31 2015
9.1% 6.8%
9.3%
15.8%
22.2%
0%
5%
10%
15%
20%
25%
30%
<40 40-49 50-74 75-84 >85
Perc
enta
ge o
f FIT
test
that
wer
e +
n=358 n=1776 n=21196 n=2767 n=883 N=26680
Target Age
17
Percent of total FIT use by age group, Alberta, April 1 2014 to December 31 2015
6.9% 7.2% 7.3% 7.3% 6.2% 6.2% 5.9%
10.5% 9.5% 8.7%
7.6% 8.5% 8.1% 7.3% 7.2%
4.6% 2.8% 2.6% 2.3% 1.6% 1.3%
0%2%4%6%8%
10%12%14%16%18%20%
Apr-Jun 2014 Jul-Sep 2014 Oct-Dec 2014 Jan-Mar 2015 Apr-Jun 2015 Jul-Sept 2015 Oct-Dec 2015
40-49
75-84
Lab age cut off notice
79.4% 80.0% 81.2% 82.4% 82.9% 84.2% 85.6%
70%
75%
80%
85%
90%
95%
100%
Apr-Jun 2014 Jul-Sep 2014 Oct-Dec 2014 Jan-Mar 2015 Apr-Jun 2015 Jul-Sept 2015 Oct-Dec 2015
50-74
Target Age
18
Number of years colonoscopy was performed before FIT+, all ages, Alberta, November 18 2013 to June 29 2015
5.6%
22.2%
19.3%
13.5%
7.7% 7.3% 5.9%
4.2% 3.5% 3.2% 3.0%
0%
5%
10%
15%
20%
25%
0 year 1 year 2 year 3 year 4 year 5 year 6 year 7 year 8 year 9 year 10 year
N=1183 * in patients who had colonoscopy prior to current FIT+
Appropriate Inteval
19
No Colonoscopy After FIT+
32.8
20.3
42.9
05
101520253035404550
No Followup (%)
305
1912
1068
3285
0
500
1000
1500
2000
2500
3000
3500
No Followup (N)
<5050-7475+Total
Diagnostic Use
20
Reasons FIT+ patients did not receive a follow-up colonoscopy, all
ages, Alberta, November 18 2013 to June 29 2015
1897
1241
135 29 1 0
250
500
750
1000
1250
1500
1750
2000
No Follow-up* Had colonscopybefore FIT+
Died Moved Had colorectalcancer
Num
ber o
f pat
ient
s
*individuals who had no colonoscopy follow-up after an index abnormal FIT within 365 days
Diagnostic Use
21
Distribution of FIT+ patients who were lost to follow-up, by age group, Alberta, November 18 2013 to June 29 2015
12.2%
60.2%
27.5%
0%
20%
40%
60%
80%
100%
<50 yrs of age (n=230) 50-74 yrs of age (n=1132) >75 yrs of age (n=517)
Diagnostic Use
22
FIT+ patients who received a follow-up colonoscopy, all ages, Alberta, November 18 2013 to June 29 2015
Number of colonoscopies
Average number of days between colonoscopies
Number of follow-up
colonoscopy patients
(N=9545)
Percent of follow-up colonoscopy
patients
1 n/a 8135 85.2%
2 134.0 1132 11.9 %
3 132.0 218 2.3 %
4 107.0 44 0.5 %
23
Limitations
• Large databases • FIT ordering opportunistic • Heterogeneous population • Extrapolation of diagnostic use
24
Conclusion
• FIT is an accepted CRC screening tool • FIT is inappropriately used in some areas
within Alberta: – Use outside of recommended age range – Ordered shorter than recommended interval – Ordered for diagnostic care
25
Next Steps
• Further audits of data • FIT age cut off • FIT repeat cut off • KT regarding FIT and symptomatic care
26
Acknowledgements • Nancy McInnis
– Project Coordinator, ACRCSP • Maria McInerney
– Project Coordinator, Screening Programs • Linan Xu
– Senior Statistical Specialist, Screening Programs • Nicole Nemecek
– Quality Nurse, ACRCSP